A new study revealed molecular features linked to more aggressive prostate cancer in a subset of patients who had been classified as low risk, highlighting biological differences that may not be apparent from clinical measures alone. The results could lead to new therapeutic strategies.
🛡️
Just a quick checkWe’re checking your connection to prevent automated abuse
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Key driver of aggressive prostate cancer identified, suggesting new way to reverse drug resistance | 0 | 9.08 | 07-10-2026 |
| 2 | Tumor markers reveal which HER2+ breast cancer patients may respond to less intensive chemotherapy | 0 | 14.44 | 06-10-2026 |
| 3 | ACS: Prostate Cancer Treatments Linked to Distinct Morbidity Patterns | 0 | 11.89 | 07-10-2026 |
| 4 | Science & Medicine: Studying the 'form and function' of prostate cancer's main driver leads to a breakthrough | 0 | 5.98 | 20-09-2026 |
| 5 | Разработана методика неинвазивной диагностики рака мочевого пузыря | 0 | 7.9 | 02-10-2026 |
| 6 | Urine Cell-Free RNA Shows Promise as Biomarker for Bladder Cancer | 0 | 15.07 | 07-10-2026 |
| 7 | Pre-Prostate Biopsy MRI Use Increased From 2017 to 2026 | 0 | 19.92 | 06-10-2026 |
| 8 | Both High and Low Testosterone Tied to Higher Atrial Fibrillation Risk | 0 | 5.5 | 25-09-2026 |
| 9 | Ученые выяснили, как выявлять рак ротовой полости по слюне | 0 | 8.8 | 02-10-2026 |
| 10 | New study finds a blood test may detect recurring breast cancer faster than a scan | 0 | 8.6 | 31-08-2026 |